Table 3 Average annual expenditure per patient

Glivec

Imatinib

30 420; 7 756^a

Sprycel

Dasatinib

49 530; 60 450^a

Tasigna

Nilotinib

47 409

Wilzin

Zinc

1 534; 495^a

Mozobil

Plerixafor

12 796

Nplate

Romiplostim

13 687

Elaprase

Idursulfase

580 952

Myozyme

Alglucosidase alfa

71 548

Increlex

Mecasermin

40 233

Kuvan

Sapropterin

43 121

Votubia

Everolimus

34 802

Cystadane

Betaine

6 315; 3 432^a

Revatio

Sildenafil

6 185

Volibris

Ambrisentan

10 434

Tracleer

Bosentan

12 697

Diacomit

Stiripentol

7 295

Arzerra

Ofatumumab

13 915

Atriance

Nelarabine

12 386

Nexavar

Sorafenib

10 535

Exjade

Deferasirox

6 527

Revolade

Eltrombopag

3 790